WG
NUVB icon

Winton Group’s Nuvation Bio NUVB Stock Holding History

Winton Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+19,400
New +$94.8K ﹤0.01% 1082
2024
Q3 		– Sell
-30,350
Closed -$88.6K – 731
2024
Q2 		$88.6K Buy
+30,350
New +$92.6K 0.01% 550

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Winton Group's NUVB Position: Q2 2026 in Review

Winton Group opened a new position in Nuvation Bio (NUVB) in Q2 2026: 19,400 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings. This is a return to the name: Winton Group previously reported a position in NUVB as recently as Q2 2024.

Winton Group first reported a position in NUVB in Q2 2024 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Winton Group held 19,400 shares of Nuvation Bio worth $110K as of Q2 2026.
  • Nuvation Bio was a new Winton Group position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1082 holding.
  • Winton Group first reported a position in Nuvation Bio in Q2 2024 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.